• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Calcium and Potassium Regulators
    15 Drugs classified under this therapeutic system


    All the Therapeutic System Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Aclasta
    Novartis
    RX
    partial basket chart
    Aclasta

    Bisphosphonate. Zoledronic Acid 5 mg / 100 ml.
    SOL. FOR INFUS: 1 x 100 ml.
    Single I.V. infus. 5 mg x 1 yr. See lit.
    Tmt. Paget’s dis. of bone. Tmt. osteoporos.
    post-menopaus. women, men at incr. risk
    fracture, incl. recent low trauma hip
    fracture. Tmt./prevent. glucocorticoidinduc.
    osteoporos. Prevent. post
    menopaus. osteoporos. in women when
    biphosphonate ther. indicat.
    C/I: Hypersens. to excips. or any
    bisphosphonates, hypocalcem., pregn.,
    lact., sev. ren. impair. (CLcr<35 mL/min).

    Alpha D3
    Teva
    RX
    full basket chart
    Alpha D3

    Vitamin D3 Analog. Alfacalcidol 0.25, 0.5, 1 mcg.
    CAPS: 50.
    Renal osteodystrophy,
    hypoparathyroidism, osteomalac. And
    rickets, osteopor., prim. and tert.
    hyperparathyroidism, neonatal hypocalc.

    Calciless
    SAM-ON
    RX
    full basket chart
    Multiple ingredients
    Calciless

    Mineral Products. Potassium Phosphate (monobasic) 602 mg, Sodium Phosphate (dibasic) 285 mg.
    TABS: 200. 3 tabs. on first day
    foll. by 2 tabs. 3 x dly.
    Prevent. and tmt. of calcium oxalate
    stones.
    C/I: Hypersens., sev. renal impair.,
    hyperphosphatemia, urolithiasis.

    Cinacalcet Taro
    Taro
    RX
    not in the basket chart
    Cinacalcet Taro

    Anti-Parathyroid Agent. Cinacalcet (as HCl) 30, 60, 90 mg.
    F.C. TABS.: 28×30, 60, 90 mg. For hyperparathyroidism: init. dosage is 30 mg (one tab.) ×1/d.
    For parathyroid cancer or prim. hyperparathyroidism: init. dosage is 30 mg (one tab.) ×2/d. Should be taken with food.
    Tmt. of second. hyperparathyroidism (HPT) in pts. with end-stage ren. dis. (ESRD) on maint. dialysis ther.
    May be used as part of a therap. regimen includ. phosphate binders and/or Vitamin D sterols, as appropr.
    Reduct. of hypercalcaemia in pts. with parathyroid carcinom.
    Reduct. of hypercalcaemia in pts. with:
    Parathyroid carcinoma.
    Prim. HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant tmt. guidelines), but in whom parathyroidectomy is not clinical. appropriate or is contraindic.
    C/I: Hypersens.

    Cinacalcet Teva
    Teva
    RX
    partial basket chart
    Cinacalcet Teva

    Anti-Parathyroid Agent. Cinacalcet (as HCl) 30, 60, 90 mg.
    TABS.: 30×60, 30 mg, 28×90 mg. Hyperparathyroidism (usual start. dose): 30 mg ×1/d.
    Parathyroid cancer, primary hyperparathyroidism (usual start. dose):30 mg×2/d.
    Tmt. of secondary HPT in ESRD on mainten. dialysis ther. May be used as part of a therap. regimen includ. phosphate binders and/or Vit. D sterols, as appropriate. Reduct. of hypercalcaemia in pts. with parathyroid carcinoma. Reduct. of hypercalcaemia in pts. with: Parathyroid Carcinoma, Primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant tmt. guidelines), but in whom parathyroidectomy is not clinic. appropriate or contraindic.
    C/I: Hypersens.

    Cinacalcet Trima
    Trima
    RX
    partial basket chart
    Cinacalcet Trima

    Anti-Parathyroid Agent. Cinacalcet 30, 60, 90 mg.
    F.C. TABS.: 14, 28, 30, 84. Usual start. is 30 mg, once per day. Parathyroid cancer/ prim. hyperparathyroidism: usual start. dose is 30mg×2/d with or shortly after food.
    Tmt. of second. HPT in pts. with ESRD on maint. dialysis ther. As part of a therap. regimen includ. phosphate binders and/ or vitamin D sterols, as appropriate. Reduct. of hypercalcaemia in pts. with:
    Parathyroid carcinoma, Primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinical. appropriate or is contraindicated.
    C/I: Hypersens.


    Other therapeutic systems under Affecting Nutrition and Metabolism

    CLOSE